Rice Hall James & Associates’s Aehr Test Systems AEHR Stock Holding History

Rice Hall James & Associates’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.41M	Sell	87,546 -184,706	-68%	-$16.9M	0.41%	68
2026 Q1	$10.1M	Sell	272,252 -181,316	-40%	-$5.8M	0.56%	53
2025 Q4	$9.16M	Buy	453,568 +9,187	+2%	+$222K	0.5%	55
2025 Q3	$13.4M	Sell	444,381 -168,071	-27%	-$3.64M	0.73%	43
2025 Q2	$7.92M	Sell	612,452 -7,888	-1%	-$75.1K	0.43%	62
2025 Q1	$4.52M	Sell	620,340 -14,051	-2%	-$155K	0.27%	81
2024 Q4	$10.5M	Buy	634,391 +235,625	+59%	+$3.14M	0.58%	50
2024 Q3	$5.12M	Buy	398,766 +59,010	+17%	+$853K	0.28%	83
2024 Q2	$3.8M	Buy	339,756 +262,469	+340%	+$3.06M	0.23%	100
2024 Q1	$958K	Buy	+77,287	New	+$1.29M	0.05%	210

Other funds holding AEHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Rice Hall James & Associates's AEHR Position: Q2 2026 in Review

Rice Hall James & Associates reduced its Aehr Test Systems (AEHR) stake by 68% in Q2 2026, selling an estimated $16.9M and leaving 87,546 shares worth $8.41M. The position accounts for 0.41% of the portfolio, ranked #68.

Rice Hall James & Associates first reported a position in AEHR in Q1 2024 and has held it in 10 quarters since. The position peaked at $13.4M in Q3 2025. 262 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

Rice Hall James & Associates held 87,546 shares of Aehr Test Systems worth $8.41M as of Q2 2026.
Rice Hall James & Associates sold 184,706 Aehr Test Systems shares in Q2 2026, an estimated $16.9M.
Aehr Test Systems made up 0.41% of Rice Hall James & Associates's portfolio in Q2 2026, its #68 holding.
Rice Hall James & Associates first reported a position in Aehr Test Systems in Q1 2024 and has held it in 10 quarters since.
Rice Hall James & Associates's Aehr Test Systems position peaked at $13.4M in Q3 2025.
262 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on Rice Hall James & Associates's 13F filing for Q2 2026, filed 7 Aug 2026.